Comments

Septerna Stock Price, Quotes and Forecasts

SEPNNASDAQ
Logo brought to you by Benzinga Data
PerksBuyCompare Brokers
PerksBuyCompare Brokers
$9.19
-0.29-3.06%
At close: -
$9.25
0.060.65%
After Hours: 7:59 PM EDT

Septerna (SEPN) Forecast

NewsEarningsSepterna (SEPN) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort Interest
Edge Rankings

Stock Score Locked: Edge Members Only

Benzinga Rankings give you vital metrics on any stock – anytime.

Unlock Rankings

Septerna Stock Price, Quotes and Forecasts | NASDAQ:SEPN | Benzinga

Explore Septerna stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for SEPN.

Open$9.31
Close$9.19
Volume / Avg.373.20K / 1.03M
Day Range$9.05 - $9.52
52 Wk Range4.17 - 28.99
Market Cap$412.16M
P/E Ratio-
Dividend Yield-
ExchangeNASDAQ
RSI
61
Short Interest
12.38%
Days to Cover16.83

Recent News

3 Stocks That Will Profit From Trump's Drug Price Cut
Trump's EO aims to lower US drug prices by using leverage of public programs (like Medicare) to force accountability. Big pharma may be hit hardest.
Nic Chahine
Ozempic Maker Novo Nordisk Looks For New Chief, Jørgensen Steps Down From CEO Role
Novo Nordisk CEO steps down after pressure from shareholders. Former CEO to join board as observer. Company remains optimistic amid mixed signals.
Akanksha Bakshi
Is It Time to Buy the Dip in Novo Nordisk Stock?
([content-module:CompanyOverview, NYSE:NVO) Despite a double beat in its quarterly earnings on May 7, Novo Nordisk A/S (NYSE:NVO) stock is still down nearly 50% in 2025. However, the stock is now trading near its
MarketBeat

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change
Analyst Trends and Forecast
1
1
Feb
1
Mar
1
1
May
Buy
Hold
Sell
Strong Sell
Analyst Rating and Forecast
12345
3.0
Hold
Strong Buy
Buy
Hold
Sell
Strong Sell
Open$9.31
Close$9.19
Volume / Avg.373.20K / 1.03M
Day Range$9.05 - $9.52
52 Wk Range4.17 - 28.99
Market Cap$412.16M
P/E Ratio-
Dividend Yield-
ExchangeNASDAQ
RSI
61
Short Interest
12.38%
Days to Cover16.83
About Septerna Inc.
Sector
Health Care
Industry
Pharmaceuticals
Septerna Inc is a clinical-stage biotechnology company pioneering a new era of G protein-coupled rec...
Show More

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
SEPN
AVIR

FAQ

Q

How do I buy Septerna (SEPN) stock?

A

You can purchase shares of Septerna (NASDAQ:SEPN) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Septerna (SEPN) competitors?

A

Other companies in Septerna’s space includes: Atea Pharmaceuticals (NASDAQ:AVIR), Theravance Biopharma (NASDAQ:TBPH), Zevra Therapeutics (NASDAQ:ZVRA), Third Harmonic Bio (NASDAQ:THRD) and GH Research (NASDAQ:GHRS).

Q

What is the forecast, or price target, for Septerna (SEPN) stock?

A

Septerna has a consensus price target of $27.00.

Q

What is the current price for Septerna (SEPN)?

A

The stock price for Septerna (NASDAQ: SEPN) is $9.25 last updated May 23, 2025 at 7:59 PM EDT.

Q

Does Septerna (SEPN) pay a dividend?

A

There are no upcoming dividends for Septerna.

Q

When is Septerna (NASDAQ:SEPN) reporting earnings?

A

Septerna’s Q2 earnings are confirmed for Friday, August 15, 2025.

Q

Is Septerna (SEPN) going to split?

A

There is no upcoming split for Septerna.

Q

What sector and industry does Septerna (SEPN) operate in?

A

Septerna is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.

People Also Watch

Connect With Us

instagramlinkedinyoutube

About Benzinga

Market Resources

Trading Tools & Education

Ring the Bell

© 2025 Benzinga | All Rights Reserved